[{"NetIncomeLoss_1_Q2_USD":-48330000.0,"PreferredStockSharesOutstanding_0_Q2_shares":0.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_0_Q2_USD":11.01,"GeneralAndAdministrativeExpense_2_Q2_USD":29192000.0,"GeneralAndAdministrativeExpense_1_Q2_USD":17451000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":91593845.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":91659829.0,"CommitmentsAndContingencies_0_Q2_USD":null,"InterestPaidNet_2_Q2_USD":1220000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":12000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0_Q2_USD":143215000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":25790000.0,"PaymentsToAcquireInvestments_2_Q2_USD":51942000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2_Q2_shares":2617056.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q2_USD":27000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q2_USD":12000.0,"LongTermDebt_0_Q2_USD":25000000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":12177894.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q2_USD":586000.0,"CommonStockSharesIssued_0_Q2_shares":91713810.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q2_USD":155435000.0,"Assets_0_Q2_USD":269648000.0,"ShareBasedCompensation_2_Q2_USD":8702000.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":12415000.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_0_Q2_USD":11970000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_2_Q2_USD":12.78,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.001,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.001,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_2_Q2_USD":18.51,"AssetsCurrent_0_Q2_USD":224555000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_2_Q2_USD":59000.0,"Liabilities_0_Q2_USD":168582000.0,"AdditionalPaidInCapitalCommonStock_0_Q2_USD":733533000.0,"ShortTermInvestments_0_Q2_USD":140556000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":65257000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":35954000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q2_USD":12.47,"RestrictedInvestmentsNoncurrent_0_Q2_USD":2150000.0,"ProceedsFromStockPlans_2_Q2_USD":392000.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":-694000.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":-285000.0,"AccountsReceivableNetCurrent_0_Q2_USD":1251000.0,"IncomeTaxExpenseBenefit_2_Q2_USD":0.0,"IncomeTaxExpenseBenefit_1_Q2_USD":0.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax_1_Q2_USD":27000.0,"CommonStockValue_0_Q2_USD":92000.0,"Revenues_2_Q2_USD":10981000.0,"Revenues_1_Q2_USD":5263000.0,"LongTermNotesPayable_0_Q2_USD":19036000.0,"AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_0_Q2_USD":14879000.0,"DepreciationDepletionAndAmortization_2_Q2_USD":2902000.0,"DepreciationDepletionAndAmortization_1_Q2_USD":1426000.0,"AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_0_Q2_USD":140544000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":1349000.0,"FairValueAssetsLevel2ToLevel1TransfersAmount_0_Q2_USD":0.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-83736000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-48303000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":1684000.0,"OtherAssetsNoncurrent_0_Q2_USD":602000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":73997000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":13828000.0,"ProceedsFromSaleMaturityAndCollectionsOfInvestments_2_Q2_USD":82378000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1_Q2_USD":16.26,"AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_0_Q2_USD":14879000.0,"FairValueAssetsLevel1ToLevel2TransfersAmount_0_Q2_USD":0.0,"CommonStockSharesAuthorized_0_Q2_shares":200000000.0,"IncreaseDecreaseInAccountsReceivable_2_Q2_USD":-8136000.0,"CommonStockSharesOutstanding_0_Q2_shares":91713810.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q2_USD":37222000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_2_Q2_USD":59000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q2_USD":27000.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_0_Q2_USD":949000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q2_USD":24000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":5078000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-69191000.0,"AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_0_Q2_USD":140556000.0,"LiabilitiesCurrent_0_Q2_USD":56165000.0,"AccountsPayableCurrent_0_Q2_USD":5450000.0,"NonoperatingIncomeExpense_2_Q2_USD":-327000.0,"NonoperatingIncomeExpense_1_Q2_USD":-188000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":73997000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":8751000.0,"ProceedsFromStockOptionsExercised_2_Q2_USD":957000.0,"OtherAccruedLiabilitiesCurrent_0_Q2_USD":1485000.0,"InterestExpenseDebt_2_Q2_USD":1428000.0,"InterestExpenseDebt_1_Q2_USD":732000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_2_Q2_shares":229730.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_0_Q2_USD":12081000.0,"PreferredStockSharesIssued_0_Q2_shares":0.0,"CapitalExpendituresIncurredButNotYetPaid_2_Q2_USD":606000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax_2_Q2_USD":0.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax_1_Q2_USD":0.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_0_Q2_USD":66872000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":15047000.0,"NetIncomeLoss_2_Q2_USD":-83795000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":-42052000.0,"IncomeTaxExaminationPenaltiesAndInterestAccrued_0_Q2_USD":0.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-632571000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q2_shares":11687959.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":9911000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":5263000.0,"OperatingIncomeLoss_2_Q2_USD":-83468000.0,"OperatingIncomeLoss_1_Q2_USD":-48142000.0,"NotesPayableCurrent_0_Q2_USD":6298000.0,"InvestmentIncomeInterest_2_Q2_USD":1795000.0,"InvestmentIncomeInterest_1_Q2_USD":829000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_2_Q2_USD":23.06,"PreferredStockValue_0_Q2_USD":null,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_2_Q2_USD":4.16,"LiabilitiesAndStockholdersEquity_0_Q2_USD":269648000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q2_USD":5203000.0,"PreferredStockSharesAuthorized_0_Q2_shares":10000000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":8702000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":5078000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_2_Q2_shares":736497.0,"PropertyPlantAndEquipmentGross_0_Q2_USD":52269000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":5675000.0,"OperatingExpenses_2_Q2_USD":94449000.0,"OperatingExpenses_1_Q2_USD":53405000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_2_Q2_USD":4839000.0,"EarningsPerShareBasicAndDiluted_2_Q2_USD":-0.91,"EarningsPerShareBasicAndDiluted_1_Q2_USD":-0.53,"OtherLiabilitiesNoncurrent_0_Q2_USD":1119000.0,"StockholdersEquity_0_Q2_USD":101066000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":3896000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q2_USD":155423000.0,"LongTermInvestments_0_Q2_USD":14879000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_2_Q2_USD":-1581000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0_Q2_shares":4886724.0,"IncreaseDecreaseInContractWithCustomerLiability_2_Q2_USD":-9911000.0,"Ticker":"MCRB","CIK":"1609809","name":"SERES THERAPEUTICS, INC.","OfficialName":"Seres Therapeutics Inc. Common Stock","form":"10-Q","period":"20210630","fy":"2021.0","fp":"Q2","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"533683334.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210803"}]